Contract facts
FederalCITRIX ELA is a federal award for Acquisitions - Aqm Momentum held by Four LLC. Estimated value $20.8M ($1.8M obligated). Current period of performance ends Sep 29, 2023 (potential Sep 29, 2026). Last award drew 3 bidders. Place of performance: HERNDON VA.
Recompete timing
PublicCurrent PoP ended Sep 29, 2023 (1057 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordFour LLC — $895.6M obligated across 1,111 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 19AQMM21F4661?
19AQMM21F4661 (CITRIX ELA) is a Acquisitions - Aqm Momentum award with a potential value of $20.8M, currently held by Four LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 19AQMM-21-F-4661?
19AQMM-21-F-4661 is the dashed form of PIID 19AQMM21F4661 (CITRIX ELA), held by Four LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 19AQMM21F4661?
Acquisitions - Aqm Momentum awarded 19AQMM21F4661 to Four LLC (potential $20.8M).
Who is the incumbent on 19AQMM21F4661?
Four LLC is the incumbent with $895.6M across 1111 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2023.
When does Four LLC’s 19AQMM21F4661 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
